ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

KRTX Karuna Therapeutics Inc

329.83
0.00 (0.00%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Karuna Therapeutics Inc KRTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 329.83 09:00:00
始値 安値 高値 終値 前日終値
329.83 329.83
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1206:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0907:01EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0120:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/3/0120:01EDGAR2Form 8-K - Current report
2024/2/2220:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2220:32EDGAR2Form 8-K - Current report
2024/2/2220:30BWKaruna Therapeutics Reports Fourth Quarter and Full Year..
2024/2/1606:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1500:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1307:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0901:56EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0606:12EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
2024/1/2220:05EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2024/1/1706:18EDGAR2Form 8-K - Current report
2024/1/1006:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0906:18EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0900:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
2023/12/3006:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2307:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2307:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2307:07EDGAR2Form 8-K - Current report
2023/12/2306:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2306:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2306:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2305:30PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
2023/12/2301:15DJNTrending: Bristol Myers to Buy Karuna Therapeutics for $14..
2023/12/2222:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2222:26EDGAR2Form 8-K - Current report
2023/12/2221:05BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
2023/12/2220:59BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
2023/12/1508:30BWKaruna Therapeutics Announces The Lancet Publication of Data..
2023/12/1306:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0905:24EDGAR2Form 144 - Report of proposed sale of securities
2023/11/3000:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
2023/11/2921:13DJNKaruna Therapeutics Gets FDA Acceptance for KarXT NDA
2023/11/2920:30BWKaruna Therapeutics Announces U.S. Food and Drug..
2023/11/1706:01BWKaruna Therapeutics Announces Positive Results from Phase 1b..
2023/11/1407:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0906:25EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0219:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0219:36EDGAR2Form 8-K - Current report
2023/11/0219:30BWKaruna Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0119:45BWKaruna Therapeutics to Present Data from the EMERGENT..
2023/11/0119:30BWKaruna Therapeutics to Present at Upcoming Investor..
2023/10/1919:30BWKaruna Therapeutics to Announce Third Quarter 2023 Financial..
2023/10/1105:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock